Table 2.
Patient number | Severity of COVID‐19 | Age (years) | Gestational age at delivery (weeks + days) | Hospital day at delivery | Reason for delivery | Mode of delivery | Respiratory support at the time of delivery | Comorbidities | Complications | Length of postpartum hospital stay (days) | Lowest P/F ratio* |
---|---|---|---|---|---|---|---|---|---|---|---|
1** | Moderate | 33 | 34+5 | 2 | Acute fatty liver of pregnancy, monochorionic‐diamniotic twins | Caesarean | None | Obesity | Postpartum endometritis, ileus | 5 | 310 |
2** | Moderate | 33 | 38+4 | 2 | Cholestasis of pregnancy | Vaginal | None | Obesity, asthma, late latent syphilis | None | 6 | 329 |
3** | Moderate | 31 | 28+5 | 1 | Pre‐eclampsia with severe features | Caesarean | None | Obesity | None | 5 | 307 |
4 | Critical | 33 | 37+2 | 3 | Labor, dichoronic‐diamniotic twins | Caesarean | None | Obesity | None | 13 | 60 |
5 | Critical | 27 | 38+0 | 5 | Labor | Caesarean | Nasal cannula | None | None | 2 | 164 |
6 | Critical | 36 | 38+0 | 2 | Labor | Vaginal | None | Obesity, lupus, bipolar disorder | Disseminated intravascular coagulopathy, postpartum hemorrhage | 5 | 96 |
7 | Critical | 27 | 38+1 | 2 | Labor, non‐reassuring fetal heart rate tracing | Caesarean | None | Obesity | None | 7 | 172 |
8 | Critical | 26 | 38+4 | 4 | Labor | Vaginal | Nasal cannula | None | None | 6 | 172 |
9 | Critical | 23 | 39+4 | 1 | Labor | Vaginal | Nasal cannula | Obesity | None | 2 | 246 |
10 | Critical | 39 | 39+2 | 1 | Scheduled repeat caesarean | Caesarean | None | Obesity | None | 4 | 216 |
11 | Critical | 32 | 36+2 | 2 | Oligohydramnios | Vaginal | Nasal cannula | Obesity | None | 3 | 181 |
12 | Critical | 23 | 33+3 | 7 | Transaminitis, fetal growth restriction, oligohydramnios | Vaginal | Nasal cannula | Obesity, asthma | None | 3 | 112 |
13 | Critical | 31 | 27+2 | 4 | Respiratory failure | Caesarean | Mechanical ventilation | Obesity | Respiratory failure | 39 | 55 |
14 | Critical | 31 | 31+0 | 4 | Respiratory failure | Caesarean | Nasal cannula | Obesity | Respiratory failure | 6 | 69 |
15*** | Critical | 18 | 31+5 | 8 | Respiratory failure | Caesarean | Mechanical ventilation | Obesity | Respiratory failure, sepsis, renal failure, liver failure, trachea‐esophageal fistula | 293 | 27 |
16 | Critical | 23 | 34+3 | 4 | Respiratory failure | Caesarean | Nasal cannula | Obesity | Respiratory failure, deep vein thrombosis | 3 | 132 |
17 | Critical | 38 | 35+5 | 2 | Respiratory failure | Caesarean | Non‐invasive mechanical ventilation | Obesity, severe asthma | Respiratory failure | 38 | 37 |
18 | Critical | 23 | 37+0 | 3 | Respiratory failure | Caesarean | Nasal cannula | Obesity | Respiratory failure | 5 | 106 |
19 | Critical | 35 | 38+0 | 2 | COVID‐19 pneumonia | Vaginal | Non‐rebreather | Obesity | Respiratory failure | 11 | 73 |
20 | Critical | 22 | 40+1 | 2 | Respiratory failure, non‐reassuring fetal heart rate tracing | Caesarean | None | None | Respiratory failure | 8 | 78 |
21***,**** | Critical | 39 | 27+1 | 3 | Perimortem | Caesarean | None*** | Obesity, diabetes | Respiratory failure with self‐extubation and cardiopulmonary arrest | 0 | 133 |
*pO2/FiO2 ratio.
**Not included in P/F ratio analysis as there was no adult respiratory distress syndrome.
***No respiratory support at the time of delivery secondary to self‐extubation.
****Not included in P/F ratio analysis due to perimortem caesarean delivery with no postpartum P/F ratios.